Search Results - "Kisselev, Alexei F"
-
1
Site-Specific Proteasome Inhibitors
Published in Biomolecules (Basel, Switzerland) (31-12-2021)“…Proteasome is a multi-subunit protein degradation machine, which plays a key role in the maintenance of protein homeostasis and, through degradation of…”
Get full text
Journal Article -
2
Early recovery of proteasome activity in cells pulse-treated with proteasome inhibitors is independent of DDI2
Published in eLife (15-04-2024)“…Rapid recovery of proteasome activity may contribute to intrinsic and acquired resistance to FDA-approved proteasome inhibitors. Previous studies have…”
Get full text
Journal Article -
3
NEIL3-mediated proteasomal degradation facilitates the repair of cisplatin-induced DNA damage in human cells
Published in Scientific reports (30-03-2023)“…Anti-neoplastic effect of DNA cross-linking agents such as cisplatin, mitomycin C, and psoralen is attributed to their ability to induce DNA interstrand…”
Get full text
Journal Article -
4
A clinically relevant pulse treatment generates a bortezomib-resistant myeloma cell line that lacks proteasome mutations and is sensitive to Bcl-2 inhibitor venetoclax
Published in Scientific reports (27-07-2022)“…Proteasome inhibitors bortezomib and carfilzomib are the backbones of treatments of multiple myeloma, which remains incurable despite many recent advances…”
Get full text
Journal Article -
5
Importance of the Different Proteolytic Sites of the Proteasome and the Efficacy of Inhibitors Varies with the Protein Substrate
Published in The Journal of biological chemistry (31-03-2006)“…The relative importance of the different proteolytic sites in mammalian proteasomes in protein degradation has not been studied systematically. Nevertheless,…”
Get full text
Journal Article -
6
A Novel Bullet Hits the Proteasome
Published in Cancer cell (09-12-2013)“…An elegant paper by Anchoori and colleagues in this issue of Cancer Cell describes an irreversible inhibitor of Rpn13, one of the ubiquitin receptors on the…”
Get full text
Journal Article -
7
Certain Pairs of Ubiquitin-conjugating Enzymes (E2s) and Ubiquitin-Protein Ligases (E3s) Synthesize Nondegradable Forked Ubiquitin Chains Containing All Possible Isopeptide Linkages
Published in The Journal of biological chemistry (15-06-2007)“…It is generally assumed that a specific ubiquitin ligase (E3) links protein substrates to polyubiquitin chains containing a single type of isopeptide linkage,…”
Get full text
Journal Article -
8
Activity of immunoproteasome inhibitor ONX-0914 in acute lymphoblastic leukemia expressing MLL–AF4 fusion protein
Published in Scientific reports (25-05-2021)“…Proteasome inhibitors bortezomib and carfilzomib are approved for the treatment of multiple myeloma and mantle cell lymphoma and have demonstrated clinical…”
Get full text
Journal Article -
9
Multiple BH3 Mimetics Antagonize Antiapoptotic MCL1 Protein by Inducing the Endoplasmic Reticulum Stress Response and Up-regulating BH3-only Protein NOXA
Published in The Journal of biological chemistry (15-07-2011)“…BH3 mimetics are small molecules designed or discovered to mimic the binding of BH3-only proteins to the hydrophobic groove of antiapoptotic BCL2 proteins. The…”
Get full text
Journal Article -
10
The Ubiquitin Ligase Activity in the DDB2 and CSA Complexes Is Differentially Regulated by the COP9 Signalosome in Response to DNA Damage
Published in Cell (02-05-2003)“…Nucleotide excision repair (NER) is a major cellular defense against the carcinogenic effects of ultraviolet light from the sun. Mutational inactivation of NER…”
Get full text
Journal Article -
11
CSA-dependent degradation of CSB by the ubiquitin-proteasome pathway establishes a link between complementation factors of the Cockayne syndrome
Published in Genes & development (01-06-2006)“…Mutations in the CSA or CSB complementation genes cause the Cockayne syndrome, a severe genetic disorder that results in patients' death in early adulthood…”
Get full text
Journal Article -
12
Molecular basis of differential sensitivity of myeloma cells to clinically relevant bolus treatment with bortezomib
Published in PloS one (27-02-2013)“…The proteasome inhibitor bortezomib (Velcade) is prescribed for the treatment of multiple myeloma. Clinically achievable concentrations of bortezomib cause…”
Get full text
Journal Article -
13
The novel β2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells
Published in Haematologica (Roma) (01-10-2015)“…Proteasome inhibitor resistance is a challenge for myeloma therapy. Bortezomib targets the β5 and β1 activity, but not the β2 activity of the proteasome…”
Get full text
Journal Article -
14
DNA-Histone Cross-Links: Formation and Repair
Published in Frontiers in cell and developmental biology (21-12-2020)“…The nucleosome is a stretch of DNA wrapped around a histone octamer. Electrostatic interactions and hydrogen bonds between histones and DNA are vital for the…”
Get full text
Journal Article -
15
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
Published in Current opinion in chemical biology (01-12-2014)“…•Structure–function relationship of subunit selective proteasome inhibitors.•Development and characterization of new inhibitors of the…”
Get full text
Journal Article -
16
The Caspase-like Sites of Proteasomes, Their Substrate Specificity, New Inhibitors and Substrates, and Allosteric Interactions with the Trypsin-like Sites
Published in The Journal of biological chemistry (19-09-2003)“…Proteasomes are the primary sites for protein degradation in mammalian cells. Each proteasome particle contains two chymotrypsin-like, two trypsin-like, and…”
Get full text
Journal Article -
17
Proteasome Active Sites Allosterically Regulate Each Other, Suggesting a Cyclical Bite-Chew Mechanism for Protein Breakdown
Published in Molecular cell (01-09-1999)“…In eukaryotes, the 20S proteasome contains two chymotrypsin-like, two trypsin-like, and two active sites shown here to have caspase-like specificity. We report…”
Get full text
Journal Article -
18
Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
Published in Chemistry & biology (27-01-2012)“…Proteasomes are large, multisubunit proteolytic complexes presenting multiple targets for therapeutic intervention. The 26S proteasome consists of a 20S…”
Get full text
Journal Article -
19
Incorporation of Fluorinated Phenylalanine Generates Highly Specific Inhibitor of Proteasome’s Chymotrypsin-like Sites
Published in Journal of medicinal chemistry (11-03-2010)“…Proteasomal processing is conducted by three individual catalytic subunits, namely β1, β2, and β5. Subunit-specific inhibitors are useful tools in dissecting…”
Get full text
Journal Article -
20
The fellowship of the ring
Published in Cancer biology & therapy (01-01-2011)“…Commentary to: Proteasome inhibitory activity of thiazole antibiotics Bulbul Pandit, Uppoor G. Bhat and Andrei Gartel…”
Get full text
Journal Article